Insider Selling: Prestige Consumer Healthcare Inc. (NYSE:PBH) SVP Sells 1,678 Shares of Stock

Prestige Consumer Healthcare Inc. (NYSE:PBH) SVP Mary Beth Fritz sold 1,678 shares of the company’s stock in a transaction dated Monday, March 10th. The shares were sold at an average price of $90.00, for a total transaction of $151,020.00. Following the sale, the senior vice president now directly owns 17,157 shares of the company’s stock, valued at $1,544,130. The trade was a 8.91 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website.

Prestige Consumer Healthcare Stock Up 0.1 %

Shares of PBH stock opened at $82.96 on Friday. The company has a debt-to-equity ratio of 0.56, a current ratio of 3.68 and a quick ratio of 2.20. Prestige Consumer Healthcare Inc. has a one year low of $62.35 and a one year high of $90.04. The company’s fifty day moving average price is $81.33 and its 200-day moving average price is $78.16. The company has a market capitalization of $4.11 billion, a price-to-earnings ratio of 19.43, a PEG ratio of 2.69 and a beta of 0.46.

Prestige Consumer Healthcare (NYSE:PBH) last posted its quarterly earnings results on Thursday, February 6th. The company reported $1.22 EPS for the quarter, beating analysts’ consensus estimates of $1.18 by $0.04. Prestige Consumer Healthcare had a return on equity of 12.36% and a net margin of 19.13%. Sell-side analysts expect that Prestige Consumer Healthcare Inc. will post 4.5 EPS for the current fiscal year.

Analyst Ratings Changes

Several brokerages recently issued reports on PBH. Raymond James upgraded shares of Prestige Consumer Healthcare to a “moderate buy” rating in a research report on Thursday, December 19th. Oppenheimer boosted their price objective on shares of Prestige Consumer Healthcare from $87.00 to $93.00 and gave the company an “outperform” rating in a research report on Thursday, February 13th. Sidoti cut Prestige Consumer Healthcare from a “buy” rating to a “neutral” rating and set a $90.00 target price on the stock. in a report on Monday, December 9th. DA Davidson lifted their target price on Prestige Consumer Healthcare from $95.00 to $104.00 and gave the company a “buy” rating in a research report on Friday, February 7th. Finally, StockNews.com cut Prestige Consumer Healthcare from a “buy” rating to a “hold” rating in a research report on Monday. Three investment analysts have rated the stock with a hold rating and three have given a buy rating to the company. According to data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $92.60.

Institutional Inflows and Outflows

Large investors have recently added to or reduced their stakes in the business. Allspring Global Investments Holdings LLC grew its holdings in Prestige Consumer Healthcare by 3.1% during the 4th quarter. Allspring Global Investments Holdings LLC now owns 1,624,501 shares of the company’s stock valued at $126,274,000 after buying an additional 49,331 shares in the last quarter. Geode Capital Management LLC lifted its holdings in shares of Prestige Consumer Healthcare by 1.7% in the fourth quarter. Geode Capital Management LLC now owns 1,348,745 shares of the company’s stock worth $105,342,000 after buying an additional 21,951 shares in the last quarter. Kayne Anderson Rudnick Investment Management LLC bought a new position in shares of Prestige Consumer Healthcare during the fourth quarter worth $84,932,000. Invesco Ltd. grew its stake in Prestige Consumer Healthcare by 2.4% during the fourth quarter. Invesco Ltd. now owns 1,060,263 shares of the company’s stock valued at $82,796,000 after acquiring an additional 24,392 shares in the last quarter. Finally, Congress Asset Management Co. increased its holdings in Prestige Consumer Healthcare by 5.0% in the 4th quarter. Congress Asset Management Co. now owns 908,742 shares of the company’s stock valued at $70,964,000 after acquiring an additional 43,619 shares during the last quarter. 99.95% of the stock is owned by hedge funds and other institutional investors.

About Prestige Consumer Healthcare

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.